Occlusive/Stenotic Peripheral artery REvascularization studY for LONG stent - OSPREY-LONG

Terumo Corporation0 个研究点目标入组 35 人开始时间: 2011年11月3日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients with terminal illness in whom life expectancy is expected to be less than 1 years (2) Patients who are participating in other clinical study of medical device or pharmaceuticals within 3months before registration (3) Patients who already participated in this study in the past. (4) Patients who previously received a bypass surgery, stent implantation or any surgery at SFA or distally (5) Scheduled for a staged procedure to treat lesions within the aorta or ipsilateral run-off vessels after enrollment (6) Patients who have allergy or experienced an anaphylactic symptom to components (Nitinol, gold etc.) of the study device (7) Patients with acute or chronic renal dysfunction (serum creatinine value is 2.0 mg/dL or greater) (8) Patients with advanced calcification or excessive tortuosity at target lesion detected by DUS/angiography (9) Patients who are pregnant or breast-feeding, or in whom these conditions are possible (10) Patients who were judged to be inappropriate for participation in the study due to severe or uncontrolled systemic disease of any condition by the principal investigators/investigators.

发起方